Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Butyldeoxynojirimycin

Trial Locations (6)

29169

Julio Arroyo, West Columbia

60612

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

94305

Stanford Univ School of Medicine, Stanford

331361013

Univ of Miami School of Medicine, Miami

921036325

Univ of California / San Diego Treatment Ctr, San Diego

02114

Harvard (Massachusetts Gen Hosp), Boston

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

G D Searle

INDUSTRY